Status:
COMPLETED
To Bathe or Not to Bathe
Lead Sponsor:
University of Portsmouth
Collaborating Sponsors:
Portsmouth Hospitals NHS Trust
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Type 2 diabetes mellitus (T2DM) is characterised by chronic high blood sugar concentration (hyperglycaemia) and insulin resistance leading to a reduction in insulin sensitivity. These hyperglycaemic e...
Detailed Description
Visit 1 (consent, screening and familiarisation) During visit 1, participants will give their informed consent, followed by a health screening questionnaire. In addition to the health screening questi...
Eligibility Criteria
Inclusion
- The participants must meet all of the following criteria to be considered eligible for the study:
- Male or female (either post-menopausal or in the early-follicular phase (3-5 days after the onset of menstruation) of the menstrual cycle), aged 35 years or above.
- Diagnosed with T2DM as defined by the WHO (World Health Organisation).
- Participant is willing and able to give informed consent for participation in the study.
- Participant is able to understand and fully cooperate with the study protocol.
- Exclusion Criteria
- The participant may not enter / be withdrawn from the study if any of the following apply:
- Severe peripheral neuropathy (to the point to which they cannot sense temperature)
- Uncontrolled hypertension (≥180 systolic / 100 diastolic mmHg)
- Taking any medication which may interfere with data interpretation or safety
- Who have had a myocardial infarction or cerebro-vascular event
- Any cardiac abnormalities which restrict hard exercise
- Current smokers or who have stopped within 3 months
- Participant is unable to understand and/or fully cooperate with the study protocol
- Any other serious medical condition which would interfere with data interpretation or safety will be excluded from participation.
- Any skin conditions including ulcerations
Exclusion
Key Trial Info
Start Date :
February 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 9 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03798717
Start Date
February 20 2019
End Date
March 9 2020
Last Update
July 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Sport and Exercise Science
Portsmouth, Hampshire, United Kingdom, PO1 2ER